Printer Friendly

NHS refuses to pay up for cancer drug.

OVARIAN cancer patients are being denied a "world first drug" on the NHS, a top scientist claims.

Olaparib treats women with the disease and those with the BRCA cancer gene but is too expensive, claims NHS advisory body Nice.

The drug kicks off a process that leads to the death of cancerous cells.

Prof Paul Workman, of the Institute of Cancer Research, said: "I'd urge Nice to make the drug available."

But Nice chief Sir Andrew Dillon said it was "uncertain" it could extend life.

It could reconsider for women who have had at least three chemo courses.

Angelina Jolie had her ovaries removed in a preven tive op after discovering she had the BRCA cancer gene.

COPYRIGHT 2015 MGN LTD
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Mirror (London, England)
Date:Aug 6, 2015
Words:117
Previous Article:Grans' duties over the hols worth PS22k.
Next Article:Baby-shake injuries dad gets 8 years.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters